Delivery Order SPE2DE24D0013-SPE2D626F36A3

Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems, was awarded a delivery order valued at $11,175.16 under a firm fixed-price contract by the Defense Logistics Agency Medical Supply Chain, with an ultimate completion date of December 24, 2025. The delivery order, designated XPRSMVP-10, carries no set-aside designation and represents ongoing procurement of diagnostic testing supplies and reagents from Cepheid's GeneXpert diagnostic platform. This award falls within the broader context of the Defense Logistics Agency's medical supply chain operations, which manages procurement and distribution of medical materiel for Department of Defense healthcare operations and affiliated federal health agencies.

Cepheid has established itself as a primary federal supplier of diagnostic solutions through extensive contracting relationships across multiple federal healthcare agencies, including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard. The company holds two significant Indefinite Delivery Contracts with the VA valued at $6.7 million and $32.8 million respectively, which generate numerous delivery orders for molecular diagnostic testing reagents, assays, and equipment support services. The firm's core competencies encompass rapid molecular diagnostic testing for infectious diseases including COVID-19, influenza, respiratory syncytial virus, tuberculosis, and antimicrobial-resistant pathogens, positioning the company as a critical supplier supporting federal clinical laboratory operations and infectious disease surveillance capabilities.